Skip to Main Content

Paper Details

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial.
Ann Oncol
26
2023
Author NameAffiliation
Ramona F SwabyMerck & Co., Inc.
Lillian L SiuPrincess Margaret Cancer Centre, University of Toronto
  • 1 - 2

Datasets

Release 1.2